Movement Disorders

Filter Your Results

 

News

 

New Monoclonal Antibodies Against Alpha-Synuclein Generated

Tuesday, June 26, 2018—ProMIS Neurosciences, Inc has announced that numerous antibodies against toxic oligomers of alpha-synuclein, implicated in Parkinson’s disease (PD) have begun the final …

Impulse Control Disorders More Common in People Who Take Dopamine Agonists

Wednesday, June 20, 2018—A French study which followed 411 people for an average of three years who had been diagnosed with Parkinson’s disease (PD) within 5 years, has reported an increase in i…

Medtronic Deep Brain Stimulation Clinician Programmer Receives FDA Approval

Wednesday, June 13, 2018—Medtronic announced that the Food and Drug Administration (FDA) had recently approved its Deep Brain Stimulation (DBS) Clinician Programmer and Activa Programming Application.…

Risk for Parkinson’s Disease May Be Linked to an Earlier Diagnosis of Diabetes

Wednesday, June 13, 2018—A study from England published online in Neurology on June 13 suggests that people with type 2 diabetes may have an increased risk of developing Parkinson&rsquo…

Medicare Benefit Coverage Available for MR-Guided Focused Ultrasound to Treat Essential Tremor

Monday, June 04, 2018—Magnetic resonance (MR)-guided focused ultrasound (MRgFUS) (INSIGHTEC, Miami, FL) for the treatment of essential tremor is now available as a medicare benefit in 10 states: Co…

BrainStorm to Host Phone Discussion of Right to Try Legislation and Stem Cell Therapy June 7th

Friday, June 01, 2018—Brainstorm Cell Therapeutics Inc (New York, NY) will host a phone call on June 7th at 8:15 AM EDT to provide interested parties an opportunity to engage with the company regar…

DaxibotulinumtoxinA Has a 24-Week Effect for Treatment of Cervical Dystonia

Friday, May 25, 2018—Phase 2 clinical trial study data for daxibotulinumtoxinA (RT002; Revance, Newark, CA) for treatment of cervical dystonia (CD) were published in the journal Movement Disorders…

Retinal Deposits of Phosphorylated Alpha-Synuclein: A Biomarker for Parkinson’s Disease?

Thursday, May 10, 2018—Analysis of retinas from 19 autopsied subjects, 9 with Parkinson’s disease (PD), and 4 with incidental Lewy body disease, showed accumulation of phosphorylated α…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC